SEC Form 4 · accession 0001144204-15-053293
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas McNaughton
Officer — Chief Financial Officer
Period of report
Aug 31, 2015
Accepted (ET)
Sep 1, 2015 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.40 | Aug 31, 2015 | A | 100,000 | A | — | Aug 31, 2025 | Common Stock, par value $0.01 per share | 100,000 | 100,000 | D |
Explanation of responses
- F1The option shares vest in four equal installments on August 31, 2016, 2017, 2018 and 2019.
Remarks
This form has been signed under power of attorney.